Cart
0

Bronchodilators Market by Diseases (Asthma, COPD, and Others), by Drugs Type (Sympathomimetics, Anticholinergics, Phosphodiesterase Inhibitor, and Combination Drugs), by Mode of Action (Long Acting Bronchodilators and Short Acting Bronchodilators), and by Route of Administration (Oral and Parenteral) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_183941
Pages: NA
Dec 2018 | 755 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Bronchodilators are used in the treatment of obstructive lung diseases by relaxing the lungs muscles and widening the airways (bronchi). They are used in the treatment of asthma and chronic obstructive pulmonary diseases (COPD).

Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.

The market is segmented on the basis of diseases, drugs type, mode of action, route of administration, and region. Based on diseases, the market is categorized into asthma, COPD, and others. By drugs type, it is classified into sympathomimetics, anticholinergics, phosphodiesterase inhibitor, and combination drugs. Based on mode of action, the market is bifurcated into long acting bronchodilators and short acting bronchodilators. On the basis of route of administration, the market is categorized into oral and parenteral. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global bronchodilators market, with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities for the period (2017‐2023) in terms of value.
  • Extensive analysis of different segments facilitates to understand various products of the market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Bronchodilators Market key Segments:

By Diseases

  • Asthma
  • COPD
  • Others (Allergic Reactions and Conditions Causing Breathing Difficulty)

By Drugs Type

  • Sympathomimetics
  • Anticholinergics
  • Phosphodiesterase Inhibitor
  • Combination Drugs

By Mode of Action

  • Long Acting Bronchodilators
  • Short Acting Bronchodilators

By Route of Administration

  • Oral
  • Parenteral

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

List of players profiled in the report

  • GlaxoSmithKline plc
  • Novartis AG
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Boehringer Ingelheim GmbH
  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group plc
  • Pfizer Inc.
 

Chapter 1 INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter 3 MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning/ market share analysis, 2017
3.4. Market dynamics

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

Chapter 4 BRONCHODILATORS MARKET, BY INDICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Asthma

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. COPD

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Others

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

Chapter 5 BRONCHODILATORS MARKET, BY MODE OF ACTION

5.1. Overview

5.1.1. Market size and forecast

5.2. Long Acting Bronchodilators

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Short Acting Bronchodilators

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

Chapter 6 BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Oral

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Parenteral

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

Chapter 7 BRONCHODILATORS MARKET, BY DRUG TYPE

7.1. Overview

7.1.1. Market size and forecast

7.2. Sympathomimetics

7.2.1. Market size and forecast

7.3. Anticholinergics

7.3.1. Market size and forecast

7.4. Phosphodiesterase Inhibitor

7.4.1. Market size and forecast

7.5. Combination Drugs

7.5.1. Market size and forecast

Chapter 8 BRONCHODILATORS MARKET, BY REGION

8.1. Overview
8.2. North America

8.2.1. Key market trends, growth factors and opportunities
8.2.2. North America bronchodilators market, by country

8.2.2.1. U.S. bronchodilators market

8.2.2.1.1. U.S. market size and forecast, by indication
8.2.2.1.2. U.S. market size and forecast, by mode of action
8.2.2.1.3. U.S. market size and forecast, by route of administration
8.2.2.1.4. U.S. market size and forecast, by drug type

8.2.2.2. Canada bronchodilators market

8.2.2.2.1. Canada market size and forecast, by indication
8.2.2.2.2. Canada market size and forecast, by mode of action
8.2.2.2.3. Canada market size and forecast, by route of administration
8.2.2.2.4. Canada market size and forecast, by drug type

8.2.2.3. Mexico bronchodilators market

8.2.2.3.1. Mexico market size and forecast, by indication
8.2.2.3.2. Mexico market size and forecast, by mode of action
8.2.2.3.3. Mexico market size and forecast, by route of administration
8.2.2.3.4. Mexico market size and forecast, by drug type

8.2.3. North America bronchodilators market, by indication
8.2.4. North America bronchodilators market, by mode of action
8.2.5. North America bronchodilators market, by route of administration
8.2.6. North America bronchodilators market, by drug type

8.3. Europe

8.3.1. Key market trends, growth factors and opportunities
8.3.2. Europe bronchodilators market, by country

8.3.2.1. Germany bronchodilators market

8.3.2.1.1. Germany market size and forecast, by indication
8.3.2.1.2. Germany market size and forecast, by mode of action
8.3.2.1.3. Germany market size and forecast, by route of administration
8.3.2.1.4. Germany market size and forecast, by drug type

8.3.2.2. France bronchodilators market

8.3.2.2.1. France market size and forecast, by indication
8.3.2.2.2. France market size and forecast, by mode of action
8.3.2.2.3. France market size and forecast, by route of administration
8.3.2.2.4. France market size and forecast, by drug type

8.3.2.3. UK bronchodilators market

8.3.2.3.1. UK market size and forecast, by indication
8.3.2.3.2. UK market size and forecast, by mode of action
8.3.2.3.3. UK market size and forecast, by route of administration
8.3.2.3.4. UK market size and forecast, by drug type

8.3.2.4. Italy bronchodilators market

8.3.2.4.1. Italy market size and forecast, by indication
8.3.2.4.2. Italy market size and forecast, by mode of action
8.3.2.4.3. Italy market size and forecast, by route of administration
8.3.2.4.4. Italy market size and forecast, by drug type

8.3.2.5. Spain bronchodilators market

8.3.2.5.1. Spain market size and forecast, by indication
8.3.2.5.2. Spain market size and forecast, by mode of action
8.3.2.5.3. Spain market size and forecast, by route of administration
8.3.2.5.4. Spain market size and forecast, by drug type

8.3.2.6. Rest of Europe bronchodilators market

8.3.2.6.1. Rest of Europe market size and forecast, by indication
8.3.2.6.2. Rest of Europe market size and forecast, by mode of action
8.3.2.6.3. Rest of Europe market size and forecast, by route of administration
8.3.2.6.4. Rest of Europe market size and forecast, by drug type

8.3.3. Europe bronchodilators market, by indication
8.3.4. Europe bronchodilators market, by mode of action
8.3.5. Europe bronchodilators market, by route of administration
8.3.6. Europe bronchodilators market, by drug type

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors and opportunities
8.4.2. Asia-Pacific bronchodilators market, by country

8.4.2.1. Japan bronchodilators market

8.4.2.1.1. Japan market size and forecast, by indication
8.4.2.1.2. Japan market size and forecast, by mode of action
8.4.2.1.3. Japan market size and forecast, by route of administration
8.4.2.1.4. Japan market size and forecast, by drug type

8.4.2.2. China bronchodilators market

8.4.2.2.1. China market size and forecast, by indication
8.4.2.2.2. China market size and forecast, by mode of action
8.4.2.2.3. China market size and forecast, by route of administration
8.4.2.2.4. China market size and forecast, by drug type

8.4.2.3. India bronchodilators market

8.4.2.3.1. India market size and forecast, by indication
8.4.2.3.2. India market size and forecast, by mode of action
8.4.2.3.3. India market size and forecast, by route of administration
8.4.2.3.4. India market size and forecast, by drug type

8.4.2.4. Australia bronchodilators market

8.4.2.4.1. Australia market size and forecast, by indication
8.4.2.4.2. Australia market size and forecast, by mode of action
8.4.2.4.3. Australia market size and forecast, by route of administration
8.4.2.4.4. Australia market size and forecast, by drug type

8.4.2.5. Rest of Asia-Pacific bronchodilators market

8.4.2.5.1. Rest of Asia-Pacific market size and forecast, by indication
8.4.2.5.2. Rest of Asia-Pacific market size and forecast, by mode of action
8.4.2.5.3. Rest of Asia-Pacific market size and forecast, by route of administration
8.4.2.5.4. Rest of Asia-Pacific market size and forecast, by drug type

8.4.3. Asia-Pacific bronchodilators market, by indication
8.4.4. Asia-Pacific bronchodilators market, by mode of action
8.4.5. Asia-Pacific bronchodilators market, by route of administration
8.4.6. Asia-Pacific bronchodilators market, by drug type

8.5. LAMEA

8.5.1. Key market trends, growth factors and opportunities
8.5.2. LAMEA bronchodilators market, by country

8.5.2.1. Brazil bronchodilators market

8.5.2.1.1. Brazil market size and forecast, by indication
8.5.2.1.2. Brazil market size and forecast, by mode of action
8.5.2.1.3. Brazil market size and forecast, by route of administration
8.5.2.1.4. Brazil market size and forecast, by drug type

8.5.2.2. Saudi Arabia bronchodilators market

8.5.2.2.1. Saudi Arabia market size and forecast, by indication
8.5.2.2.2. Saudi Arabia market size and forecast, by mode of action
8.5.2.2.3. Saudi Arabia market size and forecast, by route of administration
8.5.2.2.4. Saudi Arabia market size and forecast, by drug type

8.5.2.3. South Africa bronchodilators market

8.5.2.3.1. South Africa market size and forecast, by indication
8.5.2.3.2. South Africa market size and forecast, by mode of action
8.5.2.3.3. South Africa market size and forecast, by route of administration
8.5.2.3.4. South Africa market size and forecast, by drug type

8.5.2.4. Rest of LAMEA bronchodilators market

8.5.2.4.1. Rest of LAMEA market size and forecast, by indication
8.5.2.4.2. Rest of LAMEA market size and forecast, by mode of action
8.5.2.4.3. Rest of LAMEA market size and forecast, by route of administration
8.5.2.4.4. Rest of LAMEA market size and forecast, by drug type

8.5.3. LAMEA bronchodilators market, by indication
8.5.4. LAMEA bronchodilators market, by mode of action
8.5.5. LAMEA bronchodilators market, by route of administration
8.5.6. LAMEA bronchodilators market, by drug type

Chapter 9 COMPANY PROFILES

9.1. Abbott Laboratories

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. AstraZeneca plc

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. Boehringer Ingelheim GmbH

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. F. Hoffmann-La Roche AG

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. GlaxoSmithKline plc

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. Merck & Co., Inc.

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. Novartis AG

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. Pfizer Inc.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. Teva Pharmaceutical Industries Ltd.

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. Vectura Group plc

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
Bronchodilators Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo